Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002
Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Stroke 33:2664-2669, Scott,P.A.,et al, 2002
Two Patients With Unusual Forms of Varicella-Zoster Virus Vasculopathy
NEJM 347:1500-1503, Gilden,D.H.,et al, 2002
A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Herpes Simplex Encephalitis
JNNP, Kennedy,P.G.E.&Chaudhuri,A., 2002
Exercise-Induced Temporal Lobe Epilepsy
Neurol 59:1246-1248, Sturm,J.W.,et al, 2002
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Physician Advice, Patient Actions, and Health-Related Quality of Life in Secondary Prevention of Stroke Through Diet and Exercise
Stroke 33:565-571,570, Greenlund,K.J.,et al, 2002
Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002
An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002
Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002
PRISMS-4: Long-Term Efficacy of Interferon-B-1a in Relapsing MS
Neurol 56:1628-1636,1620, The PRISMS Study Group, 2001
Stroke in a Healthy 46-Year-Old Man
JAMA 285:2757-2762, Wityk,R.J., 2001
Functional Recovery After Rehabilitation for Cerebellar Stroke
Stroke 32:530-534, Kelly,P.J.,et al, 2001
Mild Guillain-Barre Syndrome
Arch Neurol 58:1098-1101, Green,D.M. &Ropper,A.H., 2001
A Hypothalamic Stroke Producing Recurrent Hemihyperhidrosis
Neurol 56:1394-1396, Smith,C.D., 2001
Multidisciplinary Rehabilitation for Chronic Low Back Pain: Systematic Review
BMJ 322:1511-1516, Guzman,J.,et al, 2001
An ALS-Like Syndrome with New HIV Infection and Complete Response to Antiretroviral Therapy
Neurol 57:1094-1097,945, MacGowan,D.J.L.,et al, 2001
The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001
Cardiorespiratory Fitness and the Progression of Carotid Atherosclerosis in Middle-Aged Men
Ann Int Med 134:12-20, Lakka,T.A.,et al, 2001
Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001
Use of Aspirin, Epistaxis, and Untreated Hypertension as Risk Factors for Primary Intracerebral Hemorrhage in Middle-Aged and Elderly People
Stroke 32:399-404, Saloheimo,P.,et al, 2001
Low Back Pain
NEJM 344:363-370, Deyo,R.A. &Weinstein,J.N., 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001
Atrial Fibrillation and Stroke
Stroke 32:803-808, Hart,R.G. &Halperin,J.L., 2001
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000
Angina pectoris: a Headache
Lancet 356:998, Lanza,G.A. et al, 2000
Intramuscular Interferon Beta-1a Therapy Initiated During a First Demyelinating Event in Multiple Sclerosis
NEJM 343:898-904, Jacobs,L.D. et al, 2000
Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000
Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000
Early Diagnosis of Zoster Sine Herpete and Ativiral Therapy for the Treatment of Facial Palsy
Neurol 55:708-710, Furuta,Y. et al, 2000
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000
Multiple Sclerosis--From Probable to Definite Diagnosis
Arch Neurol 57:974-979,930, Achiron,A. & Barak,Y., 2000
Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS
Neurol 54:813-817, Ge,Y.,et al, 2000
Physical Activity and Stroke Mortality in Women, Ten-Year Follow-Up of the Nord-Trondelag Health Survey, 1984-1986
Stroke 31:14-18, Ellekjaer,H.,et al, 2000
An 80-Year-Old Man With Memory Loss
JAMA 283:1046-1053, Larson,E.B., 2000
Physical Activity and Risk of Stroke in Women
JAMA 283:2961-2967, Hu,F.B.,et al, 2000
Diagnosis and Treatment of Acute Encephalitis
The Neurologist 6:145-159, Davis,L.E., 2000
Anticoagulation for Chronic Atrial Fibrillation
JAMA 283:2901-2903, Stern,S.,et al, 2000
Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999
Major Bleeding During Anticoagulation after Cerebral Ischemia, Patterns and Risk Factors
Neurol 53:1319-1327, Gorter,J.W., 1999
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999
Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999
Bell's Palsy and HSV-1 Infection
Muscle & Nerve 22:1476-1478, Marra,C.M., 1999
Benign Multiple Sclerosis? Clinical Course, Long Term Follow Up, and Assessment of Prognostic Factors
JNNP 67:148-152,138, Hawkins,S.A.&McDonnell,G.V., 1999
Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999
Randomised Conrtrolled Trial of Exercise for Low Back Pain:Clinical Outcomes, Costs, and Preferences
BMJ 319:279-283, Moffett,J.K.,et al, 1999